ArticlePharmaceuticals (Basel, Switzerland)2022

Cardiovascular Adverse Events Associated with Monoclonal Antibody Products in Patients with COVID-19.

Jingrui Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.